Bicycle Therapeutics Ltd (BCYC) — Financial Flexibility Index
Bicycle Therapeutics Ltd (BCYC) has a Financial Flexibility Index of -0.48x as of September 2025. Free cash flow of $-70.50 Million (operating CF $-71.17 Million minus capex $674.00K) represents 0% of total liabilities ($145.47 Million). Check BCYC PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bicycle Therapeutics Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Bicycle Therapeutics Ltd across 9 annual periods. See how liquid is Bicycle Therapeutics Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Bicycle Therapeutics Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Bicycle Therapeutics Ltd. For the full company profile including market capitalisation, see Bicycle Therapeutics Ltd (BCYC) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.00x | $-163.49 Million | $-164.72 Million | $163.81 Million | ▼ -288.2% |
| 2023 | -0.26x | $-57.70 Million | $-60.63 Million | $224.41 Million | ▲ +46.4% |
| 2022 | -0.48x | $-67.12 Million | $-86.11 Million | $139.83 Million | ▼ -402.2% |
| 2021 | -0.10x | $-12.76 Million | $-14.79 Million | $133.54 Million | ▲ +62.1% |
| 2020 | -0.25x | $-16.59 Million | $-17.79 Million | $65.69 Million | ▲ +84.1% |
| 2019 | -1.59x | $-27.06 Million | $-28.61 Million | $17.00 Million | ▼ -868.6% |
| 2018 | -0.16x | $-24.89 Million | $-26.08 Million | $151.45 Million | ▼ -6495.2% |
| 2017 | 0.00x | $-302.00K | $-1.42 Million | $121.19 Million | ▲ +99.9% |
| 2016 | -2.89x | $-11.02 Million | $-11.27 Million | $3.81 Million | — |